The Biden administration proposed a rule that would have required state Medicaid programs to cover GLP-1s for obesity treatment, but the Trump administration said it will leave the option up to the states
5 Things to Know When Starting a GLP-1 Receptor Agonist, with Diana Isaacs, PharmD An endocrine clinical pharmacist from the Cleveland Clinic offers tips for people starting therapy with a GLP-1 receptor agonist
By recognizing it, the prognosis of the patient can be significantly improved
In comparison to a regular blood draw, the infusion is more pleasant
Psychological and Behavioral Considerations Adolescents with obesity often face psychological distress, including depression, anxiety, and disordered eating behaviors
For an overview of how NAD compares to other IV options, see our breakdown of types of IV therapy